ClinicalTrials.Veeva

Menu

Clinical and Radiographic Outcomes of Class II Furcation Defects Management Using Propolis: A Case Series

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Enrolling
Early Phase 1

Conditions

Furcation Defects

Treatments

Drug: class II furcation defects management using propolis

Study type

Interventional

Funder types

Other

Identifiers

NCT06060340
PERIO 3-3-2

Details and patient eligibility

About

Furcation involvement represents a challenge for treatment to many periodontists due to many factors including access, morphology, and variations of anatomical features of the furcation area. Furcation involvement treatment includes non-surgical periodontal therapy, resective surgery and regenerative surgery, regenerative therapy utilizing different graft materials and membranes is of high cost and research for new materials that can be cost-effective and available for all patients is continuing, propolis have been shown to be cost-effective therapy for bone and wound healing.

Full description

Propolis is a natural resinous product of the bee workers collected from trees to use it to stick their hives and form a coat to protect their hives from all sources of bacteria and invasions. Propolis is composed of more than 300 compounds, the most important of them are flavonoids like CAPE (caffeic acid phenyl ester). Propolis have shown anti-inflammatory, anti-oxidant, anti-bacterial, anti-fungal, anti-viral and more importantly regenerative effect and bone formation capabilities.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Inclusion criteria:

    1. Lower molars with class II furcation defects.
    2. Full mouth plaque score (FMPS )<20% at baseline.
    3. Full mouth bleeding score (FMBS )<10% at baseline.
    4. Systemically healthy.
    5. Cooperative patients.

Exclusion criteria

  • Exclusion criteria:

    1. Smokers.
    2. Pregnancy and lactation.
    3. Stage 4 Grade C periodontitis.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

class II furcation defects
Experimental group
Description:
Inclusion criteria: 1. Lower molars with class II furcation defects. 2. Full mouth plaque score (FMPS )\<20% at baseline. 3. Full mouth bleeding score (FMBS )\<10% at baseline. 4. Systemically healthy. 5. Cooperative patients. Exclusion criteria: 1. Smokers. 2. Pregnancy and lactation. 3. Stage 4 Grade C periodontitis.
Treatment:
Drug: class II furcation defects management using propolis

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Said Allam, BDs; Manal Hosny, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems